开发和应用瘤病毒作为瘤细胞的敌人
Xiao Zhu1,2,3, Chenyang Fan4, Zhuolong Xiong2
1Zhejiang Provincial People's Hospital Affiliated to Hangzhou Medical College, Hangzhou Medical College, Hangzhou, China.
Frontiers in microbiology
|July 13, 2023
概括
瘤解毒病毒 (OV) 疗法通过直接破坏瘤细胞并刺激免疫反应,提供了一个有希望的替代癌症治疗方法. 最近的进展重新引起了对OVs的兴趣,突出了它们在瘤学中的潜力.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 生物疗法生物疗法
背景情况:
- 癌症治疗传统上依赖于手术,化疗和放射治疗.
- 生物疗法,包括瘤性病毒 (OV) 疗法,已成为恶性瘤的重要替代方案.
- 瘤病毒表现出抗瘤特性,如直接瘤细胞溶解和免疫反应激活.
研究的目的:
- 审查瘤病毒的发展,分类和研究进展.
- 探索OV治疗的作用机制,治疗方法和施用途径.
- 突出OV疗法在传统免疫疗法上的优势.
主要方法:
- 对型病毒的历史发展和近期研究的回顾.
- 对OV机制的分析,包括瘤细胞溶解和免疫调节.
- 检查OV治疗的不同治疗策略和施用途径.
主要成果:
- 与传统免疫疗法相比,瘤性病毒疗法表现出高杀伤效率,精确的向和较少的副作用.
- 2015年FDA批准T-VEC显著促进了对OV治疗的研究和兴趣.
- 透视疗法显示出有前途的应用前景,是癌症治疗研究的主要焦点.
结论:
- 瘤解毒病毒疗法是癌症治疗的一个不断发展和有前途的领域.
- 进一步研究OV机制和管理对于优化疗效至关重要.
- OV疗法代表了恶性瘤生物治疗领域的重大进步.
相关概念视频
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985


